InvestorsHub Logo
Followers 32
Posts 1367
Boards Moderated 0
Alias Born 10/01/2012

Re: Penny chatter post# 657

Friday, 01/26/2018 10:02:59 AM

Friday, January 26, 2018 10:02:59 AM

Post# of 1313
I think I saw the NURO diabetic pain relief product on the retail shelves but failed to realize it, as was on short time and was focused on Quell.
I am going to check back on that.

I do observe pain control ads for the diabetic foot/etc. pain control with
drugs on TV. You just know Big Pharma is not going to like electronic pain management control device . . . just like they do not want medical MJ freely available to potential pain relief seekers?

I am thinking GSK got 'pole-position' on them internationally and somewhat domestically in USA with R&D help to NURO.

Electronically mobile remote clouding interaction with medical provider monitoring and control suggestions for pain relief, probably does not 'set' well with 'cut-burn-poison' way of treatment regime?

There is a new day dawning in health care and NURO is in on it.

The one big reason I bot NURO is GSK is set-up to buy it out (or keep other Pharma from just buying it out).

NURO stock price will be jumping all over the place as 2018 progresses, as we will need more $$s for ads, etc.

I did not expect stock price to keep dropping like this either.

I probably will just buy some more when stock price and volume settle down.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NURO News